期刊文献+

临床药师参与1例术后血小板减少重症患者CRRT抗凝方案制定

Participation of Clinical Pharmacists in One Case of Severe Thrombocytopenia after Operation Treated with CRRT Anticoagulation
下载PDF
导出
摘要 目的:探讨临床药师为重症患者制定个体化连续性肾脏替代治疗(CRRT)抗凝方案的思路与方法。方法:临床药师参与1例主动脉夹层术后血小板减少重症患者CRRT的抗凝治疗方案的制定过程,分析患者血小板减少的原因及凝血功能,排除由肝素诱导血小板减少的因素,制定了在补充血小板前提下以局部构橼酸抗凝的CRRT抗凝方式。结果:患者CRRT顺利进行,CRRT治疗3天后患者肾功能恢复正常,转至普通病房。结论:临床药师深入临床,为患者制定个体化的用药方案保证了治疗效果及用药安全性。 Objective: To investigate the thoughts and the methods of clinical pharmacists in the individual continuous renal replacement therapy (CRRT) anticoagulation treatment for severe patients. Methods: Clinical pharmacists participated in the CRRT anticoagulation treatment for one patient with severe thrombocytopenia after aortic dissection surgery. Clinical pharmacists analyzed the cau- ses of thrombocytopenia and the coagulation function of the patient to exclude heparin-induced thrombocytopenia, and developed the treatment of supplementing platelets and regional citrate anticoagulation as the way of CRRT. Results: Three days after the treatment, the patient was changed to the general ward with normal renal function. Conclusion: Clinical pharmacists should participate in clinical treatment comprehensively and perform individual treatment for patients in order to ensure the effect and safety of medication.
作者 赵娟 徐航
出处 《中国药师》 CAS 2015年第12期2110-2111,共2页 China Pharmacist
关键词 血小板减少 临床药师 连续性肾脏替代治疗 抗凝 Thrombocytopenia Clinical pharmacists Continuous renal replacement therapy Anticoagulation
  • 相关文献

参考文献7

  • 1冯正义 龙村 骆秉全 等.体外循环围术期血细胞流变特性及抑肽酶的影响.中国胸心血管外科临床杂志,2000,7(2):83-85. 被引量:3
  • 2王常田,李德闽,申翼,黄海嵘,苏畅,景华.心血管手术后血小板的动态变化及其与患者预后的相关性分析[J].解放军医学杂志,2010,35(9):1145-1147. 被引量:5
  • 3Keeling D,Davidson S,Watson H,曹丽娟(编译),王兆钺(审校).肝素诱发的血小板减少治疗指南[J].国际输血及血液学杂志,2006,29(6):545-549. 被引量:5
  • 4陈香美主编..血液净化标准操作规程 2010[M].北京:人民军医出版社,2010:135.
  • 5唐无忌,徐航,葛卫红.枸橼酸钠在连续型肾脏替代治疗中的应用[J].中国药师,2014,17(7):1231-1234. 被引量:7
  • 6Santo M, Valentina P, Luigi T, et al. Regional citrate anticoagula- tion in cardiac surgery patients at high risk of bleeding : a continuous veno-venous hemofiltration protocol with a low concentration citrate solution[J]. Critical Care, 2012, 16(3) :Rlll. 被引量:1
  • 7Louise S, Azam N, Frank HB, et al. Citrate anticoagu -lation versus systemic heparinisation in continuous venovenous hemofitration in crit- ically ill patients with acute kidney injury : a multi-center randomized clinical trial[J]. Critical Care, 2014, 18(4) :472. 被引量:1

二级参考文献8

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部